A rigorous, evidence-based course equipping physicians, nurse practitioners, PAs, and wellness providers with the pharmacological knowledge and clinical protocols to confidently prescribe peptide therapies.
484
PEPTIDES DOCUMENTED IN CLINICAL STUDIES
68
FDA-APPROVED PEPTIDE THERAPEUTICS
12
IN-DEPTH CLINICAL MODULES
CE
CREDITS AVAILABLE FOR PROVIDERS
Despite 484 therapeutic peptides in clinical studies, most providers lack formal pharmacology training in this area. This course delivers the foundation needed to prescribe with clinical confidence.
Understand receptor-ligand interactions, GPCR signaling pathways, and peptide PK/PD at the mechanistic level — not just memorized protocols.
Real-world dosing frameworks, administration routes, compounding considerations, and monitoring parameters ready for immediate clinical use.
Navigate immunogenicity risks, compounding standards, off-label regulatory frameworks, and drug interactions unique to peptide therapeutics.
Grounded in peer-reviewed research and clinical pharmacology — not anecdote. Understand what evidence supports and where genuine gaps remain.
Patient intake templates, informed consent documentation, and a clinical workflow ready to deploy the week you complete training.
Peptide therapy is among the fastest-growing segments in functional and longevity medicine. Add a differentiated offering with clinical credibility.
A clinical training for licensed healthcare professionals — not an introductory consumer course. An active clinical license is required.
“The field of peptide therapeutics represents one of the most rapidly evolving areas in pharmaceutical development — bridging the gap between traditional small molecules and large protein biologics.”
Course Foundation Statement
12 Clinical Modules — Sequenced for Mastery. From foundational pharmacology through advanced clinical application and practice integration. Each module builds systematically on the last.
Structure-activity relationships, peptide vs. small molecules vs. biologics, historical evolution from insulin through modern analogs.
Peptidase degradation, half-life determinants, routes of administration, conjugation strategies: PEGylation, lipidation, Fc fusion.
GPCR signaling, receptor subtypes, downstream pathways, agonist/antagonist concepts, biased agonism.
Sermorelin, CJC-1295, Ipamorelin, Tesamorelin — indications, dosing, lab monitoring, and stacking protocols.
Semaglutide, tirzepatide, and emerging options — mechanisms, patient selection, metabolic effects, GI management.
BPC-157, TB-500 (Thymosin Beta-4) — musculoskeletal, GI healing, and neuroprotection applications.
Thymosin Alpha-1, Thymulin, KPV — immune dysregulation, autoimmune, and infection-adjacent applications.
Selank, Semax, Dihexa — neuroinflammation, anxiety, mood modulation, and the nootropic evidence base.
PT-141 (Bremelanotide) — mechanism, indications for men and women, dosing, contraindications, monitoring.
503A vs. 503B pharmacies, FDA scheduling, quality assurance, and the legal framework for off-label prescribing.
Adverse reaction identification, immunogenicity risk stratification, injection site protocols, patient education.
Patient intake templates, informed consent, pricing models, and building a sustainable peptide therapy practice.
Choose the package that best fits your practice goals. Combine courses to maximize your clinical offerings and save up to $2,000.
Don’t let budget stop you from investing in your career! We offer flexible installment payments through Klarna — split your purchase into easy, manageable payments with 0% interest.
Select Klarna at checkout and invest in your future today! 💰
“This training gave me the pharmacological foundation I was missing. I can now have confident, evidence-based conversations with patients about peptide therapy.”
Dr. M. Rivera, MD
Functional Medicine · Miami, FL
“The compounding and regulatory module alone was worth the entire course. Finally a clear framework for navigating what’s legal and what’s not in peptide prescribing.”
Jennifer K., NP
Longevity Clinic · Austin, TX
“We added peptide services within 30 days. The protocols and patient intake templates made implementation seamless — the revenue impact was immediate.”
Dr. T. Nakamura, DO
Anti-Aging Medicine · Phoenix, AZ